首页> 美国卫生研究院文献>PLoS Clinical Trials >Genetic Variation in the Proximal Promoter of ABC and SLC Superfamilies: Liver and Kidney Specific Expression and Promoter Activity Predict Variation
【2h】

Genetic Variation in the Proximal Promoter of ABC and SLC Superfamilies: Liver and Kidney Specific Expression and Promoter Activity Predict Variation

机译:ABC和SLC超家族近端启动子的遗传变异:肝脏和肾脏的特异性表达和启动子活性预测变异

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Membrane transporters play crucial roles in the cellular uptake and efflux of an array of small molecules including nutrients, environmental toxins, and many clinically used drugs. We hypothesized that common genetic variation in the proximal promoter regions of transporter genes contribute to observed variation in drug response. A total of 579 polymorphisms were identified in the proximal promoters (−250 to +50 bp) and flanking 5′ sequence of 107 transporters in the ATP Binding Cassette (ABC) and Solute Carrier (SLC) superfamilies in 272 DNA samples from ethnically diverse populations. Many transporter promoters contained multiple common polymorphisms. Using a sliding window analysis, we observed that, on average, nucleotide diversity (π) was lowest at approximately 300 bp upstream of the transcription start site, suggesting that this region may harbor important functional elements. The proximal promoters of transporters that were highly expressed in the liver had greater nucleotide diversity than those that were highly expressed in the kidney consistent with greater negative selective pressure on the promoters of kidney transporters. Twenty-one promoters were evaluated for activity using reporter assays. Greater nucleotide diversity was observed in promoters with strong activity compared to promoters with weak activity, suggesting that weak promoters are under more negative selective pressure than promoters with high activity. Collectively, these results suggest that the proximal promoter region of membrane transporters is rich in variation and that variants in these regions may play a role in interindividual variation in drug disposition and response.
机译:膜转运蛋白在一系列小分子(包括营养素,环境毒素和许多临床使用的药物)的细胞摄取和流出中起关键作用。我们假设转运蛋白基因的近端启动子区域的常见遗传变异有助于观察到药物反应的变异。在来自不同种族群体的272个DNA样本的ATP结合盒(ABC)和溶质载体(SLC)超家族的近端启动子(-250至+50 bp)和107个转运蛋白的侧翼5'序列中共鉴定到579个多态性。许多转运蛋白启动子包含多个常见的多态性。使用滑动窗口分析,我们观察到,平均而言,核苷酸多样性(π)在转录起始位点上游约300 bp处最低,表明该区域可能具有重要的功能元件。在肝脏中高表达的转运蛋白的近端启动子比在肾脏中高表达的转运蛋白具有更大的核苷酸多样性,这与对肾脏转运蛋白的启动子更大的负选择性压力相一致。使用报告基因分析评估了二十一个启动子的活性。与具有弱活性的启动子相比,在具有强活性的启动子中观察到更大的核苷酸多样性,这表明弱启动子比具有高活性的启动子承受更大的负选择压力。总的来说,这些结果表明膜转运蛋白的近端启动子区域具有丰富的变异性,并且这些区域中的变异体可能在药物配置和反应的个体差异中发挥作用。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号